In a recent study published in JAMA Network Open, researchers evaluate the risks of possible adverse events following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic...
Immunosuppressed individuals have lower responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and poorer coronavirus disease 2019 (COVID-19)-related consequences. Resistance to existing treatments, including...
In a recent study posted on medRxiv* Utilizing a preprint server, the researchers tested moderna messenger ribonucleic acid (RN) for symptomatic severe acute syndrome coronavirus 2...
In a study published in lancet microbeResearchers analyzed the current knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen or ribonucleic acid (RNA) persistence in...
In a recent study published in Nature CommunicationsResearchers are investigating the effects of a rabies messenger ribonucleic acid (mRNA) vaccine on B cell memory responses and...
In a recent article posted on medRxiv* On a preprint server, researchers present results of severe acute respiratory coronavirus 2 (SARS-CoV-2) load quantification obtained during the...
Recent Comments